semaglutide denmark Ozempic and Wegovy, Novo Nordisk's Weight Loss Drugs, Reshape Denmark's Economy Obesity drugs give Danish economy
Description
Ozempic has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease, drugmaker Novo Nordisk said Tuesday.
Shapsis calls it a metabolic breakthrough.
The drugs can also reduce the effectiveness of some forms of birth control, making unplanned pregnancies more likely.
When prescribing therapies to patients living with obesity (PwO) the median total weight loss (TWL) gives a good indication of the likely utility of prescription for that individual
This article breaks down the costs associated with GLP-1 drugs and what to consider
